There is a clear correlation between higher level of SPHK1 and poorer overall survival of the patients with lung cancer, ovarian cancer, clear cell renal cell carcinoma (ccRCC), hepatocellular carcinoma (HCC), and pancreatic cancer (Fig. 10d). The gene discussed is SPHK1; the disease is familial pancreatic carcinoma.